No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract MRCN-003/CCTGMYX.1: Weekly carfilzomib, cyclophosphamide, and dexamethasone may be a safe and effective option for patients with relapsed/refractory multiple myeloma

byKathleen Lau

March 19, 2021

in StudyGraphics

Ketamine infusion significantly reduces depressive symptoms among adolescents with treatment-resistant depression

RelatedReports

Severity of emphysema on pulmonary CT may predict lung cancer location

Chronic Disease

Age-Based Screening for Lung Cancer Surveillance in the US

November 26, 2025

Cardiology

Risk of cardiovascular mortality in patients with gastric cancer

November 10, 2025

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Chronic Disease

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

October 29, 2025

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

The Scan by 2 Minute Medicine®

World Health Organization warns that one in six infections now antibiotic resistant

October 23, 2025

Large proportion of late preterm infants and older admitted to the NICU

2 Minute Medicine Rewind March 22, 2021

Neonatal neuroimaging with strong negative predictive value for developmental outcomes: The NEURO study

Early enteral feeding safe for neonates with congenital gastrointestinal malformation undergoing intestinal anasatmosis

#VisualAbstract: ChAdOx1-nCoV-19 vaccine maintains efficacy despite a longer prime-boost interval

#VisualAbstract: Short-course antimicrobial therapy effective for pediatric community-acquired pneumonia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports